C
Carolyn L. Bayer
Researcher at Tulane University
Publications - 32
Citations - 555
Carolyn L. Bayer is an academic researcher from Tulane University. The author has contributed to research in topics: Placenta & Medicine. The author has an hindex of 11, co-authored 24 publications receiving 433 citations. Previous affiliations of Carolyn L. Bayer include University of Texas at Austin.
Papers
More filters
Journal ArticleDOI
Advances in Clinical and Biomedical Applications of Photoacoustic Imaging.
Jimmy L. Su,Bo Wang,Katheryne E. Wilson,Carolyn L. Bayer,Yun Sheng Chen,Seungsoo Kim,Kimberly A. Homan,Stanislav Emelianov +7 more
TL;DR: The technology is still in its infancy, much work has been done in the pre-clinical arena, and photoacoustic imaging is fast approaching the clinical setting, as well as some of the challenges that must be addressed to move photoac acoustic imaging into the clinical realm.
Journal ArticleDOI
Advances in recognitive, conductive and responsive delivery systems.
TL;DR: The basis of recognitive delivery systems that would be able to recognize various biomarkers and respond to their high concentrations are examined and their main mechanisms and transducing action are identified.
Journal ArticleDOI
Multiplex photoacoustic molecular imaging using targeted silica-coated gold nanorods
Carolyn L. Bayer,Yun Sheng Chen,Seungsoo Kim,Srivalleesha Mallidi,Srivalleesha Mallidi,Konstantin V Sokolov,Stanislav Emelianov +6 more
TL;DR: The use of tunable targeted silica-coated gold nanorods (SiO2-AuNRs) as contrast agents for photoacoustic molecular imaging to distinguish between the unique cell inclusions within the tissue phantom.
Journal ArticleDOI
Photoacoustic signal amplification through plasmonic nanoparticle aggregation
TL;DR: It is found that the photoacoustic signal from aggregated silica-coated gold nanoparticles is greatly enhanced in comparison to disperse silica -coatedgold nanoparticles.
Journal ArticleDOI
Photoacoustic imaging for medical diagnostics.
TL;DR: Photoacoustic imaging has the potential to provide real-time, non-invasive diagnosis of numerous prevalent diseases, due to the technology’s unique ability to visualize molecular changes deep within living tissue with spatial resolution comparable to ultrasound.